Publication in blood® Highlights Potential for GM-CSF Neutralization as a Solution for CAR-T Induced Neurotoxicity

NEXT STORY
Curetis Announces Financial Results for the First Three Months of 2019
PREV STORY
Vascepa® to Be Featured in Multiple Scientific Sessions at the National Lipid Association Annual Meeting
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cancer Genetics, Inc. to Host Panel Discussion on “The Convergence of Artificial Intelligence and Healthcare – New Developments in Precision Medicine” During the 3rd Annual Dawson James Small Cap Growth Conference on October 18th

Cancer Genetics Will Also Present a Corporate Overview on Thursday, October 19thRUTHERFORD, N.J., Oct. ...

author_avatar
NASDAQ Market News

Bio-Path Holdings to Present Data at the 2018 AACR Annual Meeting

HOUSTON, March 15, 2018 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc. (NASDAQ:BPTH), a biotechnology company ...

author_avatar
NASDAQ Market News

Key Measure of Precipio’s Pathology Sales Growth 4X Prior Quarter

NEW HAVEN, Conn., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Precipio, Inc. (NASDAQ:PRPO), announced today ...

author_avatar
NASDAQ Market News